Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1)

B. R. Seizinger, G. E. Farmer, J. L. Haines, L. J. Ozelius, K. Anderson, B. R. Korf, D. M. Parry, Margaret A Pericak-Vance, J. J. Mulvihill, A. Menon, W. J. Hobbs, R. L. Martuza, J. F. Gusella

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The defective gene causing von Recklinghausen neurofibromatosis (NF1), one of the most common inherited disorders affecting the human nervous system, was recently mapped to chromosome 17. We have used additional DNA markers to further narrow and bracket the NF1 defect. A multipoint linkage analysis suggests that the NF1 gene is flanked by D17Z1 on the centromeric side and by EW207 on the telomeric side of the long arm of chromosome 17. The identification of closely linked flanking markers should allow us to develop a reliable prenatal and presymptomatic diagnostic test for this serious neurological disorder and provides the basis for applying chromosome-specific cloning techniques for the isolation and characterization of the mutant gene.

Original languageEnglish
Pages (from-to)30-32
Number of pages3
JournalAmerican Journal of Human Genetics
Volume44
Issue number1
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Neurofibromatoses
Chromosomes, Human, Pair 17
Genes
Nervous System Diseases
Genetic Markers
Routine Diagnostic Tests
Nervous System
Organism Cloning
Chromosomes

ASJC Scopus subject areas

  • Genetics

Cite this

Seizinger, B. R., Farmer, G. E., Haines, J. L., Ozelius, L. J., Anderson, K., Korf, B. R., ... Gusella, J. F. (1989). Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1). American Journal of Human Genetics, 44(1), 30-32.

Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1). / Seizinger, B. R.; Farmer, G. E.; Haines, J. L.; Ozelius, L. J.; Anderson, K.; Korf, B. R.; Parry, D. M.; Pericak-Vance, Margaret A; Mulvihill, J. J.; Menon, A.; Hobbs, W. J.; Martuza, R. L.; Gusella, J. F.

In: American Journal of Human Genetics, Vol. 44, No. 1, 01.01.1989, p. 30-32.

Research output: Contribution to journalArticle

Seizinger, BR, Farmer, GE, Haines, JL, Ozelius, LJ, Anderson, K, Korf, BR, Parry, DM, Pericak-Vance, MA, Mulvihill, JJ, Menon, A, Hobbs, WJ, Martuza, RL & Gusella, JF 1989, 'Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1)', American Journal of Human Genetics, vol. 44, no. 1, pp. 30-32.
Seizinger BR, Farmer GE, Haines JL, Ozelius LJ, Anderson K, Korf BR et al. Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1). American Journal of Human Genetics. 1989 Jan 1;44(1):30-32.
Seizinger, B. R. ; Farmer, G. E. ; Haines, J. L. ; Ozelius, L. J. ; Anderson, K. ; Korf, B. R. ; Parry, D. M. ; Pericak-Vance, Margaret A ; Mulvihill, J. J. ; Menon, A. ; Hobbs, W. J. ; Martuza, R. L. ; Gusella, J. F. / Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1). In: American Journal of Human Genetics. 1989 ; Vol. 44, No. 1. pp. 30-32.
@article{d367016ca5b24644b9b4c13150551c0c,
title = "Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1)",
abstract = "The defective gene causing von Recklinghausen neurofibromatosis (NF1), one of the most common inherited disorders affecting the human nervous system, was recently mapped to chromosome 17. We have used additional DNA markers to further narrow and bracket the NF1 defect. A multipoint linkage analysis suggests that the NF1 gene is flanked by D17Z1 on the centromeric side and by EW207 on the telomeric side of the long arm of chromosome 17. The identification of closely linked flanking markers should allow us to develop a reliable prenatal and presymptomatic diagnostic test for this serious neurological disorder and provides the basis for applying chromosome-specific cloning techniques for the isolation and characterization of the mutant gene.",
author = "Seizinger, {B. R.} and Farmer, {G. E.} and Haines, {J. L.} and Ozelius, {L. J.} and K. Anderson and Korf, {B. R.} and Parry, {D. M.} and Pericak-Vance, {Margaret A} and Mulvihill, {J. J.} and A. Menon and Hobbs, {W. J.} and Martuza, {R. L.} and Gusella, {J. F.}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "44",
pages = "30--32",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1)

AU - Seizinger, B. R.

AU - Farmer, G. E.

AU - Haines, J. L.

AU - Ozelius, L. J.

AU - Anderson, K.

AU - Korf, B. R.

AU - Parry, D. M.

AU - Pericak-Vance, Margaret A

AU - Mulvihill, J. J.

AU - Menon, A.

AU - Hobbs, W. J.

AU - Martuza, R. L.

AU - Gusella, J. F.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The defective gene causing von Recklinghausen neurofibromatosis (NF1), one of the most common inherited disorders affecting the human nervous system, was recently mapped to chromosome 17. We have used additional DNA markers to further narrow and bracket the NF1 defect. A multipoint linkage analysis suggests that the NF1 gene is flanked by D17Z1 on the centromeric side and by EW207 on the telomeric side of the long arm of chromosome 17. The identification of closely linked flanking markers should allow us to develop a reliable prenatal and presymptomatic diagnostic test for this serious neurological disorder and provides the basis for applying chromosome-specific cloning techniques for the isolation and characterization of the mutant gene.

AB - The defective gene causing von Recklinghausen neurofibromatosis (NF1), one of the most common inherited disorders affecting the human nervous system, was recently mapped to chromosome 17. We have used additional DNA markers to further narrow and bracket the NF1 defect. A multipoint linkage analysis suggests that the NF1 gene is flanked by D17Z1 on the centromeric side and by EW207 on the telomeric side of the long arm of chromosome 17. The identification of closely linked flanking markers should allow us to develop a reliable prenatal and presymptomatic diagnostic test for this serious neurological disorder and provides the basis for applying chromosome-specific cloning techniques for the isolation and characterization of the mutant gene.

UR - http://www.scopus.com/inward/record.url?scp=0024562297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024562297&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 30

EP - 32

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -